CANN GROUP LIMITED — Director's Dealing 2018

Apr 12, 2018

==> picture [585 x 60] intentionally omitted <==

ASX ANNOUNCEMENT

13 APRIL 2018

CHANGE OF DIRECTOR’S INTEREST

Please find following a Change of Director’s Interest Notice (Appendix 3Y).

Richard Baker

Company Secretary

Cann Group Limited

For further information please contact: Peter Crock Matthew Wright Cann Group Limited NWR Communications +61 (0) 3 9095 7088 +61 (0) 451 896 420 contact@canngrouplimited.com matt@nwrcommunications.com.au

About Cann Group

Cann Group is building a world-class business focused on breeding, cultivating and manufacturing medicinal cannabis for sale and use within Australia and internationally (once exports are permitted). The company has established research and cultivation facilities in Melbourne and is striving to provide access to medicinal cannabis for Australian patients. Cann Group has executed collaboration agreements that will enable it to establish a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. It was issued with Australia’s first medicinal cannabis research licence in February 2017, in addition to Australia’s first medicinal cannabis cultivation licence in March 2017. Aurora Cannabis Inc – one of Canada’s largest listed medicinal cannabis companies – is a cornerstone investor in Cann, with a 22.9% shareholding.

==> picture [595 x 78] intentionally omitted <==

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity CANN GROUP LIMITED

ABN 25 603 949 739

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	GEOFFREY PEARCE
Date of last notice	25 JANUARY 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	INDIRECT
Nature of indirect interest	EGEA PTY LTD
(including registered holder)	•Director of EGEA Pty Ltd; and
Note: Provide details of the circumstances giving rise to the relevantinterest.	•Shareholder of EGEA Pty Ltd
Date of change	12 APRIL 2018
No. of securities held prior to change	1,377,040
Class	FULLY PAID ORDINARY SHARES
Number acquired	103,672
Number disposed	NIL
Value/Consideration	$266,182
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change	1,480,712

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change ON-MARKET PURCHASE Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buyback

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to	N/A
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details and
an estimated valuation
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed	N/A
above traded during a+closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the	N/A
trade to proceed during this period?
If prior written clearance was provided, on what date was	N/A
this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011